Literature DB >> 19816080

Cancer stem cells in solid tumors.

Ozlem Er1.   

Abstract

Carcinogenesis and tumor cell biology are very complex subjects. Recent findings on cancer stem cells may have a great impact on the understanding of the biology of malignancies and the development of future treatment approaches. Cancer stem cells are defined by their potential to self-renew and differentiate. Identification of cancer stem cells is possible by detecting expression of a certain combination of various cell surface markers and also by functional assays. The cancer stem cell concept was originally developed for hematological malignancies but is now becoming accepted for solid tumors as well. Emerging data indicates that cancer stem cells are responsible for the growth and spread of tumors. There is still a long way to go in characterizing cancer stem cells and understanding their role in carcinogenesis. Further studies should lead to a greater understanding of the biology of these cells with significant implications for diagnosis, treatment, and prevention of cancer. The recent studies regarding stem cell origin of various solid tumors will be discussed briefly in this review. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19816080     DOI: 10.1159/000232375

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  6 in total

1.  Endothelial derived factors inhibit anoikis of head and neck cancer stem cells.

Authors:  Marcia S Campos; Kathleen G Neiva; Kristy A Meyers; Sudha Krishnamurthy; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-10-19       Impact factor: 5.337

2.  (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.

Authors:  Ya-Jun Li; Shun-Long Wu; Song-Mei Lu; Fang Chen; Ying Guo; Sheng-Min Gan; Yan-Long Shi; Shuang Liu; Shao-Lin Li
Journal:  Tumour Biol       Date:  2014-12-07

3.  The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.

Authors:  Su-Ni Tang; Chandan Singh; Dara Nall; Daniel Meeker; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Mol Signal       Date:  2010-08-18

4.  A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma.

Authors:  Ye-Bin Pang; Jian He; Bi-Yu Cui; Sheng Xu; Xi-Lei Li; Man-Ya Wu; Rong Liang; Yan Feng; Xing Guo; Xue-Hui Zhang; Xiao-Ling Luo
Journal:  Stem Cells Int       Date:  2019-04-01       Impact factor: 5.443

Review 5.  Cancer stem cell theory: therapeutic implications for nanomedicine.

Authors:  Ke Wang; Xianguo Wu; Jianwei Wang; Jian Huang
Journal:  Int J Nanomedicine       Date:  2013-02-28

6.  Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer.

Authors:  Fernanda S Giudice; Decio S Pinto; Jacques E Nör; Cristiane H Squarize; Rogerio M Castilho
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.